Related Experiment Videos
Editorial: biomarker predictors of non-response to TNFα antagonists - the quest continues. Authors' reply
Bram Verstockt1,2, Séverine Vermeire1,2, Marc Ferrante1,2
1KU Leuven Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium.
Alimentary Pharmacology & Therapeutics
|March 29, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Distinct intestinal eosinophil subsets in ulcerative colitis and their modulation by advanced inflammatory bowel disease therapies.
Journal of Crohn's & colitis·2026
Isolated perianal fistulizing Crohn's disease in contemporary clinical practice: a multicenter ECCO-CONFER cohort study.
Journal of Crohn's & colitis·2026
Positioning Guselkumab in The Treatment Algorithm for Ulcerative Colitis.
Journal of inflammation research·2026
Clinical Trial: Dupilumab Improves Eosinophilic Oesophagitis Outcomes Versus Placebo Regardless of Comorbidities or Treatment History in a Randomised Clinical Trial.
Alimentary pharmacology & therapeutics·2026
The TOP-GERD Trial: Comparative Efficacy of Tegoprazan Versus Pantoprazole in the Treatment of Erosive Oesophagitis in a Non-Asian Population.
Alimentary pharmacology & therapeutics·2026
Review Article: Beyond the Therapeutic Ceiling in Inflammatory Bowel Disease-Mechanism-Based Positioning and Emerging Therapeutic Strategies.
Alimentary pharmacology & therapeutics·2026
Systematic Review: Inclusion of Patients With Difficult-to-Treat Inflammatory Bowel Disease in Randomized Controlled Trials of Advanced Therapies.
Alimentary pharmacology & therapeutics·2026
Clinical trial: The Effect on Intragastric pH and Pharmacokinetics of the PCAB Linaprazan Glurate in Healthy Subjects After Repeat-Dose Administration for up to 14 Days.
Alimentary pharmacology & therapeutics·2026
Accelerated Biological Aging in Cholestatic Liver Disease: Telomere Attrition and Association With Disease Severity.
Alimentary pharmacology & therapeutics·2026
MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy.
Molecular carcinogenesis·2026
Impact of PD-1 and PD-L1 inhibitors on patient-reported outcomes in esophageal squamous cell carcinoma: a systematic review of clinical trials.
Current medical research and opinion·2026
Prognostic Value of Primary Tumor and Immune Organ Metabolic Parameters Derived from Pretreatment 18F-FDG PET/CT in Gastric Adenocarcinoma: A Retrospective Survival Analysis.
Molecular imaging and radionuclide therapy·2026
Cell-based polygenic risk scores predict clinical progression and prioritize network-based therapeutic targets in Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2026